Click here to view original web page at www.globenewswire.com
WALTHAM, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, will hold a conference call and live audio webcast on October 1, 2019, at 8:30 a.m. Eastern Time to […]